Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease ; volume:10 ; number:1 ; day:28 ; month:7 ; year:2018 ; pages:1-10 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (28.7.2018), 1-10, 12.2018
- Urheber
- Beteiligte Personen und Organisationen
-
Ermann, Natalia
Andreasson, Ulf
Schultheis, Christian
Podhorna, Jana
Spitzer, Philipp
Maler, Juan Manuel
Kornhuber, Johannes
Blennow, Kaj
Zetterberg, Henrik
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0404-9
- URN
-
urn:nbn:de:101:1-2018092911570737929491
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lewczuk, Piotr
- Ermann, Natalia
- Andreasson, Ulf
- Schultheis, Christian
- Podhorna, Jana
- Spitzer, Philipp
- Maler, Juan Manuel
- Kornhuber, Johannes
- Blennow, Kaj
- Zetterberg, Henrik
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Der N-Methyl-D-Aspartat (NMDA)-Rezeptor im menschlichen Gehirn : experimentelle Studien unter besonderer Berücksichtigung der Schizophrenien
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration